Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.

Side-effects associated with ketamine use in depression: a systematic review

Open access
Short, Brooke, Fong, Joanna, Galvez, Veronica, Shelker, William, Loo, Colleen K·2018·The Lancet Psychiatry

Abstract

This is the first systematic review of the safety of ketamine in the treatment of depression after single and repeated doses. We searched MEDLINE, PubMed, PsycINFO, and Cochrane Databases and identified 288 articles, 60 of which met the inclusion criteria. After acute dosing, psychiatric, psychotomimetic, cardiovascular, neurological, and other side-effects were more frequently reported after ketamine treatment than after placebo in patients with depresssion. Our findings suggest a selective reporting bias with limited assessment of long-term use and safety and after repeated dosing, despite these being reported in other patient groups exposed to ketamine (eg, those with chronic pain) and in recreational users. We recommend large-scale clinical trials that include multiple doses of ketamine and long-term follow up to assess the safety of long-term regular use.

Overview

Integrity signals

Registry

Crossref · 10.1016/s2215-0366(17)30272-9

Cites

117 of 117 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

1 retracted

Show all 117 references

Research works printed but not linked: 7

  1. Worthington, 2015, Ketamine offered to patients with depression in take-home, DIY packs by controversial clinic, ABC News
  2. Kembrey, 2015, Medical clinics promote ketamine injections as treatment for depression, Sydney Morning Herald
  3. Bella, 2015, Could ketamine become the next great depression drug?, Aljazeera America
  4. Singh, 2013, Efficacy and safety of intravenous esketamine in patients with treatment-resistant depression: a double-blind, double-randomization, placebo controlled phase 2a study, Neuropsychopharmacology, 38, s369
  5. Quinones, 2012, Experience integrating ketamine into the healthcare system: outpatient and inpatient treatment of post-partum depression, suicidal ideation and comorbid chronic pain-mood disorders, Neuropsychopharmacology, 38, s442
  6. Kalsi, 2011, The epidemiology and patterns of acute and chronic toxicity associated with recreational ketamine use, Emerg Health Threats J, 4, 7107, 10.3402/ehtj.v4i0.7107 · DOI · Paper page
  7. Jansen, 2000, Anaesthetic apocalypse. Ketamine part 2: addictive psychedelic, Druglink, 18

Cited by

See all 558

Metadata

Authors
Short, B., Fong, J., Galvez, V., Shelker, W., & Loo, C. K.
Affiliations
  • Black Dog Institute (AU)
  • UNSW Sydney (AU)
  • University of Otago (NZ)
Corresponding author
Loo, Colleen K
Venue
The Lancet Psychiatry
Publisher
Elsevier BV
Published
2018-01
Volume
5
Issue
1
Pages
65-78
ISSN
2215-0366 (ISSN-L)
OpenAlex
W2741959390
Cited by
558
References
117
Citations by year
2026: 53 · 2025: 76 · 2024: 78 · 2023: 64 · 2022: 79 · 2021: 73 · 2020: 60 · 2019: 40 · 2018: 31
FWCI
4.69
Type
journal article
Language
en
Open access
Licence
  • cc-by-nc-nd
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
  • UNSWorks (UNSW Sydney) (submittedVersion, cc-by-nc-nd)
  • UNSWorks (University of New South Wales, Sydney, Australia) (submittedVersion, cc-by-nc-nd)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
  • Life Sciences › Neuroscience › Neurology › Transcranial Magnetic Stimulation Studies
Keywords
ketamine, depression, drug safety, adverse effects, psychotomimetic effects, cardiovascular effects, neurological effects, psychiatric adverse effects, repeated dosing, long-term use, selective reporting
MeSH terms
Long Term Adverse Effects, Anesthetics, Dissociative, Antidepressive Agents, Dose-Response Relationship, Drug, Drug Administration Schedule, Humans, Ketamine, Treatment Outcome, Depressive Disorder, Treatment-Resistant

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Side-effects associated with ketamine use in depression: a systematic review. https://app.cochat.ai/papers/10.1016/s2215-0366(17)30272-9
The paper
Short, B., Fong, J., Galvez, V., Shelker, W., & Loo, C. K. (2018). Side-effects associated with ketamine use in depression: a systematic review. The Lancet Psychiatry. https://doi.org/10.1016/s2215-0366(17)30272-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.